Eliem Therapeutics, Inc. (ELYM)
NASDAQ: ELYM · IEX Real-Time Price · USD
8.25
+0.07 (0.86%)
May 17, 2024, 4:00 PM EDT - Market closed

Company Description

Eliem Therapeutics, Inc., a biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in psychiatry, epilepsy, chronic pain, and other disorders of the peripheral and central nervous systems.

The company was incorporated in 2018 and is headquartered in Wilmington, Delaware.

Eliem Therapeutics, Inc.
Eliem Therapeutics logo
Country United States
Founded 2018
IPO Date Aug 10, 2021
Industry Biotechnology
Sector Healthcare
Employees 9
CEO Dr. Andrew Levin M.D., Ph.D.

Contact Details

Address:
2801 Centerville Road 1st Floor, Pmb #117
Wilmington, Delaware 19808
United States
Phone 877-354-3689
Website eliemtx.com

Stock Details

Ticker Symbol ELYM
Exchange NASDAQ
Fiscal Year January - December
Reporting Currency USD
IPO Price $12.50
CIK Code 0001768446
CUSIP Number 28658R106
ISIN Number US28658R1068
Employer ID 83-2273741
SIC Code 2834

Key Executives

Name Position
Dr. Andrew Levin M.D., Ph.D. Principal Financial Officer and Executive Chairman
Dr. Valerie Morisset Ph.D. Chief Scientific Officer and Executive Vice President of Research and Development
Emily Pimblett Principal Accounting Officer
Jo Palmer-Phillips Ph.D. Chief Development Officer

Latest SEC Filings

Date Type Title
May 17, 2024 PREM14A Filing
May 17, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
May 17, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
May 15, 2024 10-Q Quarterly Report
May 7, 2024 SC 13G Statement of acquisition of beneficial ownership by individuals
Apr 29, 2024 10-K/A [Amend] Annual report
Apr 12, 2024 SC 13D/A [Amend] General statement of acquisition of beneficial ownership
Apr 11, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Apr 11, 2024 8-K Current Report
Mar 28, 2024 S-8 Securities to be offered to employees in employee benefit plans